Kopran Ltd. — Regulatory Filings 2021

Dec 11, 2021

==> picture [101 x 87] intentionally omitted <==

11[th] December, 2021

The Manager BSE Limited Corporate Relationship Department P. J. Towers, Dalal Street, Mumbai – 400 001.

BSE Scrip Code No. 524280

The Manager

The National Stock Exchange of India Limited Exchange Plaza, Bandra - Kurla Complex, Bandra (E), Mumbai – 400 051.

NSE Symbol : KOPRAN

Dear Sir/Madam,

Sub: Press Release

We are pleased to inform you that the Indian Patent office has granted Process Patent No. IN384085 for 20 years to Kopran Research Laboratories Limited, Wholly owned Subsidiary of the Company for the Active Pharmaceutical Ingredient (API) product NITROXOLINE , for the invention titled “ IMPROVED, COST EFFECTIVE PROCESS FOR PRODUCING NITROXOLINE “

Kindly dissipate the information on the Exchange website.

Regards,

For Kopran Limited

==> picture [90 x 52] intentionally omitted <==

Sunil Sodhani Company Secretary & Compliance Officer Membership No. FCS 3897

==> picture [52 x 70] intentionally omitted <==

KOPRAN LTD.: Parijat House, 1076, Dr. E. Moses Road, Worli, Mumbai - 400 018. P. B. No. 9917, Tel.: (022) 4366 1111 Fax: (022) 2495 0363 Website: www.kopran.com CIN – L 24230 MH 1958 PLC 011078. Works:• Village Savroli, Taluka: Khalapur, District: Raigad - 410 202. Tel.: (02192) 274500 / 335 / 337• Fax: (02192) 274025